Constitutive activation of IKKβ in adipose tissue prevents diet-induced obesity in mice

Endocrinology

Volumn 153, Issue 1, 2012, Pages 154-165

  Jiao, Ping ^a,d   Feng, Bin ^a,e   Ma, Jie ^b,d   Nie, Yaohui ^a   Paul, Erin ^c   Li, Yujie ^a   Xu, Haiyan ^a  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c BROWN UNIVERSITY   (United States)

^d JILIN UNIVERSITY   (China)

^e HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; FATTY ACID BINDING PROTEIN 4; GLUCOSE; I KAPPA B KINASE BETA; INSULIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIET INDUCED OBESITY; ENERGY EXPENDITURE; ENZYME ACTIVATION; FATTY ACID BLOOD LEVEL; FATTY LIVER; FOOD INTAKE; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HISTOPATHOLOGY; INFLAMMATION; INSULIN SENSITIVITY; LIVER; MOUSE; MUSCLE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; TISSUE DISTRIBUTION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; DIET, HIGH-FAT; EATING; ENERGY METABOLISM; ENZYME ACTIVATION; FATTY ACID-BINDING PROTEINS; FEMALE; GENE EXPRESSION; I-KAPPA B KINASE; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OBESITY; PROMOTER REGIONS, GENETIC;

EID: 84455191537     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1346     Document Type: Article

References (32)

1. Festa A, D'Agostino Jr R, Howard G, Mykkänen L, Tracy RP, Haffner SM 2000 Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 102:42-47 (Pubitemid 30430551)
2. Pickup JC, Mattock MB, Chusney GD, Burt D 1997 NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40:1286-1292 (Pubitemid 27469668)
3. Shoelson SE, Lee J, Goldfine AB 2006 Inflammation and insulin resistance. J Clin Invest 116:1793-1801 (Pubitemid 44033299)
4. Hotamisligil GS 2006 Inflammation and metabolic disorders. Nature 444:860-867 (Pubitemid 46024993)
5. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM 1994 Tumor necrosis factor α inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 91:4854-4858 (Pubitemid 24177748)
6. Amrani A, Jafarian-Tehrani M, Mormède P, Durant S, Pleau JM, Haour F, Dardenne M, Homo-Delarche F 1996 Interleukin-1 effect on glycemia in the non-obese diabetic mouse at the pre-diabetic stage. J Endocrinol 148:139-148 (Pubitemid 26017042)
7. Fried SK, Bunkin DA, Greenberg AS 1998 Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83:847-850 (Pubitemid 28496456)
8. Sartipy P, Loskutoff DJ 2003 Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA 100:7265-7270 (Pubitemid 36706427)
9. Senn JJ, Klover PJ, Nowak IA, Mooney RA 2002 Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51:3391-3399 (Pubitemid 35403441)
10. Rotter V, Nagaev I, Smith U 2003 Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 278:45777-45784 (Pubitemid 37432722)
11. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H 2003 Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830 (Pubitemid 38063705)
12. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW 2003 Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808 (Pubitemid 38063703)
13. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE 2001 Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkβ. Science 293: 1673-1677 (Pubitemid 32807849)
14. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE 2005 Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-≲καππα∀B. Nat Med 11:183-190 (Pubitemid 40321354)
15. Zhang X, Zhang G, Zhang H, Karin M, Bai H, Cai D 2008 Hypothalamic IKKβ/NF-≲καππα∀B and ER stress link overnutrition to energy imbalance and obesity. Cell 135:61-73
16. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M 2005 IKK-β links inflammation to obesity-induced insulin resistance. Nat Med 11: 191-198 (Pubitemid 40321355)
17. Hotamisligil GS, Erbay E 2008 Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol 8:923-934
18. Schenk S, Saberi M, Olefsky JM 2008 Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 118:2992-3002
19. Ouchi N, Parker JL, Lugus JJ, Walsh K 2011 Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11:85-97
20. Tang T, Zhang J, Yin J, Staszkiewicz J, Gawronska-Kozak B, Jung DY, Ko HJ, Ong H, Kim JK, Mynatt R, Martin RJ, Keenan M, Gao Z, Ye J 2010 Uncoupling of inflammation and insulin resistance by NF- ≲καππα∀B in transgenic mice through elevated energy expenditure. J Biol Chem 285:4637-4644
21. Gao Z, Hwang D, Bataille F, Lefevre M, York D, Quon MJ, Ye J 2002 Serine phosphorylation of insulin receptor substrate 1 by inhibitor ≲καππα∀B kinase complex. J Biol Chem 277:48115-48121 (Pubitemid 35470759)
22. Berg AH, Lin Y, Lisanti MP, Scherer PE 2004 Adipocyte differentiation induces dynamic changes in NF-≲καππα∀B expression and activity. Am J Physiol Endocrinol Metab 287:E1178-E1188 (Pubitemid 39491960)
23. Jiao P, Ma J, Feng B, Zhang H, Alan Diehl J, Eugene Chin Y, Yan W, Xu H 2011 FFA-induced adipocyte inflammation and insulin resistance: involvement of ER stress and IKKβ pathways. Obesity 19:483-491
24. Ross SR, Graves RA, Greenstein A, Platt KA, Shyu HL, Mellovitz B, Spiegelman BM 1990 A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo. Proc Natl Acad Sci USA 87:9590-9594 (Pubitemid 120016489)
25. Tam J, Vemuri VK, Liu J, Bátkai S, Mukhopadhyay B, Godlewski G, Osei-Hyiaman D, Ohnuma S, Ambudkar SV, Pickel J, Makriyannis A, Kunos G 2010 Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity. J Clin Invest 120:2953-2966
26. Jiao P, Chen Q, Shah S, Du J, Tao B, Tzameli I, Yan W, Xu H 2009 Obesity-related upregulation of monocyte chemotactic factors in adipocytes: involvement of nuclear factor-≲καππα∀B and c-Jun NH2-terminal kinase pathways. Diabetes 58:104-115
27. Xu H, Hirosumi J, Uysal KT, Guler AD, Hotamisligil GS 2002 Exclusive action of transmembrane TNF α in adipose tissue leads to reduced adipose mass and local but not systemic insulin resistance. Endocrinology 143:1502-1511 (Pubitemid 34274381)
28. Blüher M, Michael MD, Peroni OD, Ueki K, Carter N, Kahn BB, Kahn CR 2002 Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 3:25-38 (Pubitemid 34778393)
29. Morino K, Petersen KF, Shulman GI 2006 Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 55(Suppl 2):S9-S15 (Pubitemid 44927027)
30. Patti ME, Corvera S 2010 The role of mitochondria in the pathogenesis of type 2 diabetes. Endocr Rev 31:364-395
31. Tisdale MJ 1997 Biology of cachexia. J Natl Cancer Inst 89:1763-1773 (Pubitemid 27516230)
32. Wallenius V, Wallenius K, Ahrén B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, Jansson JO 2002 Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8:75-79 (Pubitemid 34101732)